REMUS PHARMACEUTICALS LIMITED

Ajouter à une liste

Autres langues Remus Pharmaceuticals Limited

Actions

REMUS

INE0O5T01011

Produits pharmaceutiques

Temps Différé NSE India S.E. 09:48:37 08/10/2026			Varia. 5j.	Varia. 1 janv.
960,00 ^INR	+12,12%		+6,29%	+36,71%

21/05	Remus Pharmaceuticals Limited publie ses résultats pour le quatrième trimestre clos le 31 mars 2026	CI
10/11	Remus Pharmaceuticals Limited publie ses résultats semestriels au 30 septembre 2025	CI

Autres langues

31/05	295,000 Equity Shares of Remus Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 31-MAY-2026.
21/05	Remus Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
10/11	Remus Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2025
29/08/25	Remus Pharmaceuticals re-appoints Arpit Shah as managing director
20/06/25	Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
17/05/25	Remus Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2025
18/12/24	Remus Pharmaceuticals Limited Incorporates Subsidiary in Guatemala
09/11/24	Remus Pharmaceuticals Limited Approves Interim Dividend for Fiscal Year 2024-25
09/11/24	Remus Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2024
31/05/24	790,000 Equity Shares of Remus Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 31-MAY-2024.
16/05/24	Remus Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
23/04/24	Remus Pharmaceuticals Limited Declare Second Interim Dividend for the Financial Year 2023-24
31/03/24	Remus Pharmaceuticals Limited completed the acquisition of a 51% stake in Espee Biopharma & Finechem LLC.
07/02/24	Remus Pharmaceuticals Limited Announces Setting Up of Branch Office in Dubai
15/09/23	Remus Pharmaceuticals Limited entered into a Memorandum of Understanding to acquire a 51% stake in Espee Biopharma & Finechem LLC for $2.7 million.
23/05/23	Remus Pharmaceuticals Limited has completed an IPO in the amount of INR 476.852 million.
13/03/23	Remus Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
10/03/23	Remus Pharmaceuticals Limited has filed an IPO.

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Bourse
Actions
Action REMUS
Actualités Remus Pharmaceuticals Limited
Autres langues

Les meilleurs outils réservés aux abonnés pour augmenter la performance de vos investissements !